Cargando…
Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide
OBJECTIVE: The aim of this study is to investigate whether ambroxol inhibits inflammatory responses in a murine model of lipopolysaccharide-induced acute lung injury (ALI). METHODS: Mice (n=295) were first intratracheally instilled with lipopolysaccharide (LPS) to induce ALI and then received an int...
Autores principales: | Su, Xiao, Wang, Ling, Song, Yuanlin, Bai, Chunxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227363/ https://www.ncbi.nlm.nih.gov/pubmed/14504727 http://dx.doi.org/10.1007/s00134-003-2001-y |
Ejemplares similares
-
Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
por: Patzwaldt, Kristin, et al.
Publicado: (2023) -
Ambroxol Treatment Suppresses the Proliferation of Chlamydia pneumoniae in Murine Lungs
por: Kókai, Dávid, et al.
Publicado: (2021) -
Role of mucolytics in the management of COPD
por: Poole, Phillippa J
Publicado: (2006) -
Mucolytic treatment of chronic rhinosinusitis in a murine model of primary ciliary dyskinesia
por: Yin, Weining, et al.
Publicado: (2023) -
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020)